PharmiWeb Today Story
Roche has announced a $50 billion investment in the United States over the next five years, aiming to create over 12,000 jobs. This strategic move is in response to potential tariffs from the Trump administration targeting Swiss pharmaceutical imports. The investment will expand manufacturing and distribution centers in Kentucky, Indiana, New Jersey, and California.
New facilities include a gene therapy plant in Pennsylvania, a continuous glucose monitoring site in Indiana, a weight loss drug factory at an undisclosed location, and a cardiovascular, renal, and metabolism research center in Massachusetts. CEO Thomas Schinecker emphasized that this initiative will position Roche to export more medicines from the U.S. than it imports, reinforcing the company's commitment to U.S. innovation and growth. This development follows similar U.S. investment plans by Novartis, Eli Lilly, and Johnson & Johnson.
Read More...
Articles

What Does a Pharmaceutical Account Manager Do?
04-Mar-2025

Top 10 Highest Paying Pharma Jobs in 2025
18-Feb-2025

The Impact of AI on Pharmaceutical Sales
13-Feb-2025

What Does a Medical Science Liaison Do?
18-Sep-2023
Featured Events

-
Reuters Events: Pharma 2021
11-Oct-2021 - 22-Oct-2021 -
HFpEF Drug Discovery & Development Summit 2022
25-Jan-2022 - 27-Jan-2022 -
UK Clinical Research: A Professional Awareness Upd…
26-Jan-2022 - 27-Jan-2022 -
Bioprocessing and the future of food
06-Jul-2022 - 07-Jul-2022 -
Finding the Value in Strategic Outsourcing Partner…
22-Feb-2023 - 22-Feb-2023 -
Global Biomanufacturing Summit
25-May-2023 - 26-May-2023
News

-
Abivax Announces Annual General Meeting Details as…
22-Apr-2025 -
Abivax Announces Appointment of Dominik Höchli, MD…
22-Apr-2025 -
Dr. James Orbinski Joins Onco-Innovations' Scienti…
22-Apr-2025 -
Medicure to Present Financial Results on April 29,…
22-Apr-2025 -
Invitation: Straumann Group 2025 first-quarter res…
22-Apr-2025 -
Aptevo Therapeutics Announces the Closing of $2.0…
22-Apr-2025